The investigation of the responses to phytohemagglutinin in the patients of non-Hodgkin's lymphoma who were candidates for high dose chemotherapy, autologous bone marrow or peripheral stem cell transplantation

AGEITOS, Ana; TALMADGE, James E.; ŞENOL, Mustafa; ÖZEROL, İ. Halil

The investigation of the responses to phytohemagglutinin in the patients of non-Hodgkin's lymphoma who were candidates for high dose chemotherapy, autologous bone marrow or peripheral stem cell transplantation

İ. Halil ÖZEROL, (Univercity of Nebraska, Department, of Pathology/Microbiology, Omaha, NE 68198, USA)

Mustafa ŞENOL, (Girilmedi)

Ana AGEITOS, (Girilmedi)

James E. TALMADGE (Girilmedi)

İnönü Üniversitesi Turgut Özal Tıp Merkezi Dergisi

1 0

Yıl: 1996 Cilt: 3 Sayı: 4 Sayfa Aralığı: 306 - 310 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

The investigation of the responses to phytohemagglutinin in the patients of non-Hodgkin's lymphoma who were candidates for high dose chemotherapy, autologous bone marrow or peripheral stem cell transplantation

Öz:

Fitohemaglutinin (PHA), genellikle bir T lenfosit mitojenidir. CD4+ helper/inducer T lenfositlerine, CD8' suppressor/cytotoxic T lenfositlerine göre daha fazla stimulator etki yapar. Bu çalışmada, biz normal periferik kan lökositleri (PBL) ile otolog kemik iliği (BM) ve granulosit-monosit koloni stîmulan faktör (GM-CSF) ile mobilize edilmiş periferik stem cell (PSC) ürünlerinin PHA 'e verdikleri mitojenik cevapların farklı olup olmadığını araştırdık. Non-Hodgkin lenfomalı 24 hastadan kemik iliği ve periferik stem cell ürünleri toplandı ve IL-2 ile 5 gün kültür yapılmadan önce ve yapıldıktan sonra PHA hücre proliferasyon cevabı incelendi. Hem PSC hem de BM hücrelerinin PHA proliferatif cevapları anlamlı şekilde normal PBL 'den düşüktü (p<0.01). PSC'in PHA cevabı BM'unkinden daha yüksekti (p<0 05). IL-2 ile kültür yapıldıktan sonra PBL'nin PHA cevabı azaldı (p<0.05) fakat PSC ve BM'unki değişmedi. Bu çalışma sonucunda IL-2 ile inkübasyona PSC ürünleri PHA'e daha yüksek mitojenik cevap verdi. Bu sonuçlara göre non-Hodgkin lenfomalı hastaların lenfositlerindeki deprese mitojenik cevap, membrana bağlı IL-2'nin sürekli stimüle olması nedeniyle yüksek baz proliferasyona sebep olduğunu düşündürmektedir. [Turgut Özal Tıp Merkezi Dergisi 1996;3(4):306-310]

Anahtar Kelime:

Konular: Genel ve Dahili Tıp

Yüksek doz kemoterapi, otolog kemik iliği veya periferik stem cell transplantasyonu yapılacak non-Hodgkin lenfomalı hastalarda fitohemaglutinin'e cevabın araştırılması

Öz:

Phytohemagglutinin (PHA) is principally a T lymphocyte mitogen, producing a greater stimulatory effect* on CD4+ helper/inducer T lymphocytes than on CD8+ suppressor/cytotoxic T cells. In this study, investigated if there are differences in the mitogenic response to PHA between autologous bone marrow " (BM) and granulocyte-monocyte colony stimulating factor (GM-CSF)-mobilized peripheral stem cell (PSC) products as well as to normal peripheral blood leukocytes (PBL). BM and PSC products from 24 patients with non-Hodgkin's lymphoma (NHL) were collected and assays of cell proliferation in response to PHA were performed both before and following 5 days co-incubation with IL^2. The proliferative response to PHA by cells from both PSC and BM products were significantly lower than normal PBL (p<0.00I). The PHA response of PSC was significantly higher than that observed with BM (p<0.01). The response to PHA of PSC was higher than BM (p<0.05). When compared before culture with IL-2, the PHA response of PBL was decreased (p<0.05), but PSC and BM was not changed. This study showed that the PSC products prior to IL-2 incubation had higher mitogenic response to PHA. According to these results the depressed mitogenic response of lymphocytes from non-Hodgkin patients was associated with an increase in "baseline" proliferation due to membrane bound IL-2 resulting in continued proliferation. [Journal of Turgut Özal-Medical.Centerl996;3(4):306-310]

Anahtar Kelime:

Konular: Genel ve Dahili Tıp

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1.Cruise JM, Lewis RE. Illustrated Dictionary ofImmunology. New York. CRC press. 1995:206.
2.Oppenheim JJ, Ruscetti FW, Faltynek C. Cytockines. In:Stites DP, Terr AI, Parslow TG, (eds). Basic and ClinicalImmunology. 8th ed. Norwalk. Appleton and Lange.1994:105-23.
3.Gibson FM, Malkovska V, Myint AA, et al. Mechanism ofsuppression of normal hematopoietic activity bylymphokine-activated killer cells and their products. ExpHematol 1991; 19:659-73.
4.Lum LG. The kinetics of immune reconstitution after humanmarrow transplantation. Blood 1987; 69:369-80.
5.Lum LG, Ueda M. Immunodeficiency and the role ofsuppressor cells after human bone marrow transplantation.Clin Immunol Immunopathol 1992; 63:103-9.
6.Gottschalk LR, Bray RA, Kaizer H, Gebel HM. Twopopulations of CD56 (Leu-19)+ /CD16+ cells in bonemarrow transplant recipients. Bone Marrow Transplant1990; 5:259-64.
7.Talmadge JE, Reed EC, Kessinger A, et al. Immunologicattributes of cytockine mobilized peripheral blood stem cellsand recovery following transplantation in non-Hodgkin’slymphoma patients. Bone Marrow Transplant 1996; 17:101-9.
8.Smith KA. Interleukin-2: Inception, impact, andimplications. Science 1988; 240:1169-76.
9.Gratwohl A, Hermans J, Baldomero H. Hematopoieticprecursor cell transplantation in Europa: Activity in 1994.Report from the European group for Blood and MarrowTransplantation (EBMT). Bone Marrow Transplant 1996;17:137-48.
10.Goldman JM. Peripheral blood stem cells for allografting.Blood 1995; 85: 1413-6.
11.Korbling M, Juttner C, Henon P, Kessinger A. Autologousblood stem cell versus bone marrow transplantation. BoneMarrow Transplant 1992; 10 (Suppl 1): 144-8.
12.Bell AJ, Figes A, Oscier DG, Hamblin TJ. Peripheral bloodstem cell autografts in the treatment of lymphoidmalignancies: initial experience in three patients. Br JHaematol 1987; 66: 63-8.
13.Gribben JG, Freedman AS, Neuberg D, et al. Immunologicpurging of marrow assessed by PCR before autologous bonemarrow transplantation for B-cell lymphoma. N Engl J Med1991; 325: 1525-33.
14.Caligiuri MA, Zmuidzinas A, Manley TJ, Levine H, SmithKA, Ritz J. Functional consequences of interleukin-2receptor expression on resting human lymphocytes:Identification of a novel natural killer cell subset with highaffinity receptors. J Exp Med 1990; 171:1509-26.
15.Farace F, Angevin E, Dietrich P-R, et al. Low-dose IL-2treatment: Activation of discrete T- and NK-cell sub-populations in vivo. Int J Cancer 1995; 62:523-8.
16.Thatcher N, Gasiunas N, Crowther D. Lymphocyte functionin the blood of patients with untreated non-Hodgkinlymphoma: Influence of stage and pathology. Med PedOncol 1977; 3:311-21.
17.Noguchi S, Bukowski R, Deodhar S, Hewlett JS. T and Blymphocytes in non-Hodgkin’s lymphoma. Cancer 1976;23:89-98.
18.Talmadge JE. The combination of stem cell transplantationand immunotherapy: Future potential. In Vivo 1994;8(5):675-90

APA	ÖZEROL İ, ŞENOL M, AGEITOS A, TALMADGE J (1996). The investigation of the responses to phytohemagglutinin in the patients of non-Hodgkin's lymphoma who were candidates for high dose chemotherapy, autologous bone marrow or peripheral stem cell transplantation. , 306 - 310.
Chicago	ÖZEROL İ. Halil,ŞENOL Mustafa,AGEITOS Ana,TALMADGE James E. The investigation of the responses to phytohemagglutinin in the patients of non-Hodgkin's lymphoma who were candidates for high dose chemotherapy, autologous bone marrow or peripheral stem cell transplantation. (1996): 306 - 310.
MLA	ÖZEROL İ. Halil,ŞENOL Mustafa,AGEITOS Ana,TALMADGE James E. The investigation of the responses to phytohemagglutinin in the patients of non-Hodgkin's lymphoma who were candidates for high dose chemotherapy, autologous bone marrow or peripheral stem cell transplantation. , 1996, ss.306 - 310.
AMA	ÖZEROL İ,ŞENOL M,AGEITOS A,TALMADGE J The investigation of the responses to phytohemagglutinin in the patients of non-Hodgkin's lymphoma who were candidates for high dose chemotherapy, autologous bone marrow or peripheral stem cell transplantation. . 1996; 306 - 310.
Vancouver	ÖZEROL İ,ŞENOL M,AGEITOS A,TALMADGE J The investigation of the responses to phytohemagglutinin in the patients of non-Hodgkin's lymphoma who were candidates for high dose chemotherapy, autologous bone marrow or peripheral stem cell transplantation. . 1996; 306 - 310.
IEEE	ÖZEROL İ,ŞENOL M,AGEITOS A,TALMADGE J "The investigation of the responses to phytohemagglutinin in the patients of non-Hodgkin's lymphoma who were candidates for high dose chemotherapy, autologous bone marrow or peripheral stem cell transplantation." , ss.306 - 310, 1996.
ISNAD	ÖZEROL, İ. Halil vd. "The investigation of the responses to phytohemagglutinin in the patients of non-Hodgkin's lymphoma who were candidates for high dose chemotherapy, autologous bone marrow or peripheral stem cell transplantation". (1996), 306-310.

APA	ÖZEROL İ, ŞENOL M, AGEITOS A, TALMADGE J (1996). The investigation of the responses to phytohemagglutinin in the patients of non-Hodgkin's lymphoma who were candidates for high dose chemotherapy, autologous bone marrow or peripheral stem cell transplantation. İnönü Üniversitesi Turgut Özal Tıp Merkezi Dergisi, 3(4), 306 - 310.
Chicago	ÖZEROL İ. Halil,ŞENOL Mustafa,AGEITOS Ana,TALMADGE James E. The investigation of the responses to phytohemagglutinin in the patients of non-Hodgkin's lymphoma who were candidates for high dose chemotherapy, autologous bone marrow or peripheral stem cell transplantation. İnönü Üniversitesi Turgut Özal Tıp Merkezi Dergisi 3, no.4 (1996): 306 - 310.
MLA	ÖZEROL İ. Halil,ŞENOL Mustafa,AGEITOS Ana,TALMADGE James E. The investigation of the responses to phytohemagglutinin in the patients of non-Hodgkin's lymphoma who were candidates for high dose chemotherapy, autologous bone marrow or peripheral stem cell transplantation. İnönü Üniversitesi Turgut Özal Tıp Merkezi Dergisi, vol.3, no.4, 1996, ss.306 - 310.
AMA	ÖZEROL İ,ŞENOL M,AGEITOS A,TALMADGE J The investigation of the responses to phytohemagglutinin in the patients of non-Hodgkin's lymphoma who were candidates for high dose chemotherapy, autologous bone marrow or peripheral stem cell transplantation. İnönü Üniversitesi Turgut Özal Tıp Merkezi Dergisi. 1996; 3(4): 306 - 310.
Vancouver	ÖZEROL İ,ŞENOL M,AGEITOS A,TALMADGE J The investigation of the responses to phytohemagglutinin in the patients of non-Hodgkin's lymphoma who were candidates for high dose chemotherapy, autologous bone marrow or peripheral stem cell transplantation. İnönü Üniversitesi Turgut Özal Tıp Merkezi Dergisi. 1996; 3(4): 306 - 310.
IEEE	ÖZEROL İ,ŞENOL M,AGEITOS A,TALMADGE J "The investigation of the responses to phytohemagglutinin in the patients of non-Hodgkin's lymphoma who were candidates for high dose chemotherapy, autologous bone marrow or peripheral stem cell transplantation." İnönü Üniversitesi Turgut Özal Tıp Merkezi Dergisi, 3, ss.306 - 310, 1996.
ISNAD	ÖZEROL, İ. Halil vd. "The investigation of the responses to phytohemagglutinin in the patients of non-Hodgkin's lymphoma who were candidates for high dose chemotherapy, autologous bone marrow or peripheral stem cell transplantation". İnönü Üniversitesi Turgut Özal Tıp Merkezi Dergisi 3/4 (1996), 306-310.